Progesterone Receptor Positive Tumor: Max 1 Line of Prior Chemotherapy, no Prior Hormone Therapy
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase 1-2 Study of Onapristone in Patients With Progesterone Receptor Expressing Cancers (NCT02052128) | Arno Therapeutics | 2014-01-01 |
Track Progesterone Receptor Positive Tumor: Max 1 Line of Prior Chemotherapy, no Prior Hormone Therapy automatically
Every clearance here is in the API, with alerts when new ones post.